chr1-214614833-TTGAAAATGAAAAAACCGAGGGTACAAACC-T

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PP5_Moderate

The NM_016343.4(CENPF):​c.171_199delTGAAAAAACCGAGGGTACAAACCTGAAAA​(p.Asn57LysfsTer11) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000263 in 152,094 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000032 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CENPF
NM_016343.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 9.25

Publications

0 publications found
Variant links:
Genes affected
CENPF (HGNC:1857): (centromere protein F) This gene encodes a protein that associates with the centromere-kinetochore complex. The protein is a component of the nuclear matrix during the G2 phase of interphase. In late G2 the protein associates with the kinetochore and maintains this association through early anaphase. It localizes to the spindle midzone and the intracellular bridge in late anaphase and telophase, respectively, and is thought to be subsequently degraded. The localization of this protein suggests that it may play a role in chromosome segregation during mitotis. It is thought to form either a homodimer or heterodimer. Autoantibodies against this protein have been found in patients with cancer or graft versus host disease. [provided by RefSeq, Jul 2008]
CENPF Gene-Disease associations (from GenCC):
  • Stromme syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Illumina, Genomics England PanelApp, Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 1-214614833-TTGAAAATGAAAAAACCGAGGGTACAAACC-T is Pathogenic according to our data. Variant chr1-214614833-TTGAAAATGAAAAAACCGAGGGTACAAACC-T is described in ClinVar as [Pathogenic]. Clinvar id is 224501.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CENPFNM_016343.4 linkc.171_199delTGAAAAAACCGAGGGTACAAACCTGAAAA p.Asn57LysfsTer11 frameshift_variant Exon 3 of 20 ENST00000366955.8 NP_057427.3 P49454
CENPFXM_017000086.3 linkc.171_199delTGAAAAAACCGAGGGTACAAACCTGAAAA p.Asn57LysfsTer11 frameshift_variant Exon 3 of 20 XP_016855575.1 P49454
CENPFXM_011509082.4 linkc.171_199delTGAAAAAACCGAGGGTACAAACCTGAAAA p.Asn57LysfsTer11 frameshift_variant Exon 3 of 19 XP_011507384.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CENPFENST00000366955.8 linkc.171_199delTGAAAAAACCGAGGGTACAAACCTGAAAA p.Asn57LysfsTer11 frameshift_variant Exon 3 of 20 1 NM_016343.4 ENSP00000355922.3 P49454
CENPFENST00000706765.1 linkc.171_199delTGAAAAAACCGAGGGTACAAACCTGAAAA p.Asn57LysfsTer11 frameshift_variant Exon 3 of 19 ENSP00000516538.1 A0A9L9PXU7
CENPFENST00000464322.5 linkn.339_367delTGAAAAAACCGAGGGTACAAACCTGAAAA non_coding_transcript_exon_variant Exon 3 of 3 2
CENPFENST00000706764.1 linkn.349_377delTGAAAAAACCGAGGGTACAAACCTGAAAA non_coding_transcript_exon_variant Exon 3 of 7

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152094
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000364
AC:
8
AN:
219866
AF XY:
0.0000502
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000762
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000325
AC:
46
AN:
1415568
Hom.:
0
AF XY:
0.0000256
AC XY:
18
AN XY:
702122
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
31144
American (AMR)
AF:
0.00
AC:
0
AN:
35068
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24284
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38948
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78244
European-Finnish (FIN)
AF:
0.0000190
AC:
1
AN:
52530
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5422
European-Non Finnish (NFE)
AF:
0.0000412
AC:
45
AN:
1091546
Other (OTH)
AF:
0.00
AC:
0
AN:
58382
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.359
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152094
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41418
American (AMR)
AF:
0.00
AC:
0
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000843
Hom.:
0
Bravo
AF:
0.0000340

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Stromme syndrome Pathogenic:2
Aug 29, 2023
Baylor Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 19, 2025
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
9.3
Mutation Taster
=10/190
disease causing (ClinVar)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs757575602; hg19: chr1-214788176; API